Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance

British Journal of Haematology

Volumn 134, Issue 5, 2006, Pages 485-490

  Pepe, Jessica ^a   Petrucci, Maria Teresa ^a   Nofroni, Italo ^a   Fassino, Valeria ^a   Diacinti, Daniele ^a   Romagnoli, Elisabetta ^a   Minisola, Salvatore ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bone mineral density; Bone turnover; Fracture; Monoclonal gammopathy of undetermined significance; Osteoporosis

Indexed keywords

BIOCHEMICAL MARKER; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; BONE REMODELING; COLLES FRACTURE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; OSTEOPOROSIS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; SPINE FRACTURE; VERTEBRA FRACTURE;

AGED; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; CARRIER PROTEINS; DENSITOMETRY, X-RAY; FEMALE; FEMUR NECK; GLYCOPROTEINS; HIP; HUMANS; LINEAR MODELS; LUMBAR VERTEBRAE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MONOCLONAL GAMMOPATHIES, BENIGN; NECK; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPROTEGERIN; PREVALENCE; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; ROC CURVE; SENSITIVITY AND SPECIFICITY; SPINAL FRACTURES;

EID: 33746512510     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06217.x     Document Type: Article

References (25)

1. Cockcroft, D.W. & Gault, M.H. (1976) Prediction of creatinine clearance from serum creatinine. Nephron, 16, 31-41.
2. Dhodapkar, M.V., Weinstein, R., Tricot, G., Jagannath, S., Parfitt, A.M., Manolagas, S.C. & Barlogie, B. (1998) Biologic and therapeutic determinants of bone mineral density in multiple myeloma. Leukemia and Lymphoma, 32, 121-127.
3. Diamond, T., Levy, S., Smith, A., Day, P. & Manoharan, A. (2001) Non-invasive markers of bone turnover and plasma cytokines differ in osteoporotic patients with multiple myeloma and monoclonal gammopathies of undetermined significance. Internal Medicine Journal, 31, 272-278.
4. Duan, Y., Turner, C.H., Kim, B.T. & Seeman, E. (2001) Sexual dimorphism in vertebral fragility is more the result of gender differences in age-related bone gain than bone loss. Journal of Bone and Mineral Research, 16, 2267-2275.
5. Genant, H.K., Wu, C.Y., van Kuijk, C. & Nevitt, M.C. (1993) Vertebral fracture assessment using a semiquantitative technique. Journal of Bone and Mineral Research, 9, 1137-1148.
6. Genant, H.K., Jergas, M., Palermo, L., Nevitt, M., Valentin, R.S., Black, D. & Cummings, S.R. (1996) Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The study of osteoporotic fractures research group. Journal of Bone and Mineral Research, 11, 984-996.
7. Giuliani, N., Bataille, R., Mancini, C., Lazzaretti, M. & Barille, S. (2001) Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment. Blood, 98, 3527-2533.
8. Gomez, B., Jr., Ardakani, S., Ju, J., Jenkins, D., Cerelli, M.J., Daniloff, G.Y. & Kung, V.T. (1995) Monoclonal antibody assay for measuring bone specific alkaline phosphatase activity in serum. Clinical Chemistry, 41, 1560-1566.
9. Hernandez, J.M., Suquia, B., Queizan, J.A., Fisac, R.M., Sanchez, J.J., Fernandez-Calvo, F.J., Garcia-Sanz, R., Olivier, C., Barez, A., Calmuntia, M.J., Garcia-Frade, J., Portero, J.A., Lopez, R., Aguilera, C., Navajo, J.A. & San-Miguel, J.F. (2004) Bone remodelation markers are useful in the management of monoclonal gammopathies. The Hematology Journal, 5, 480-488.
10. 125I labeled tracer. Clinical Chemistry, 39, 529-533.
11. Jakob, C., Zavrski, I., Heider, U., Brux, B., Fucker, J., Langelotz, C., Sinha, P., Possinger, K. & Sezer, O. (2002) Bone resorption parameters (carboxy-terminal telopeptide of type I collagen (ICTP), amino-terminal collagen type I telopeptide (NTx), and deoxypyridinoline (DpD) in MGUS and multiple myeloma. European Journal of Haematology, 69, 17-42.
12. Karmatschek, M., Maier, I., Seibel, M.J., Woitge, H.W., Ziegler, R. & Armbruster, F.P. (1997) Improved purification of human bone sialoprotein and development of a homologous radioimmunoassay. Clinical Chemistry, 43, 2076-2082.
13. Kyle, R.A., Gertz, M.A., Witzig, T.E., Lust, J.A., Lacy, M.Q., Dispenzieri, A., Fonseca, R., Rajkumar, S.V., Offord, J.R., Larson, D.R., Plevak, M.E., Therneau, T.M. & Greipp, P.R. (2003) Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clinic Proceedings, 78, 21-33.
14. Melton, L.J. 3rd, Rajkumar, S.V., Khosla, S., Achenbach, S.J., Oberg, A.L. & Kyle, R.A. (2004) Fracture risk in monoclonal gammopathy of undetermined significance. Journal of Bone and Mineral Research, 19, 25-30.
15. Minisola, S., Pacitti, M.T., Scarda, A., Rosso, R., Romagnoli, E., Carnevale, V., Scarnecchia, L. & Mazzuoli, G.F. (1993) Serum ionized calcium, parathyroid hormone and related variables: effects of age and sex. Bone and Mineral, 23, 183-193.
16. Minisola, S., Pacitti, M.T., Romagnoli, E., Rosso, R., Carnevale, V., Caravella, P., Scillitani, A. & Dicembrino, F. (1999) Clinical validation of a new immunoradiometric assay for intact human osteocalcin. Calcified Tissue International, 64, 365-369.
17. Pecherstorfer, M., Seibel, M.J., Woitge, H.W., Horn, E., Schuster, J., Neuda, J., Sagaster, P., Kohn, H., Bayer, P., Thiebaud, D. & Ludwig, H. (1997) Bone resorption in multiple myeloma and in monoclonal gammopathy of undetermined significance: quantification by urinary pyridinium cross-links of collagen. Blood, 90, 3743-3750.
18. Pepe, J., Romagnoli, E., Nofroni, I., Pacitti, M.T., De Geronimo, S., Letizia, C., Tonnarini, G., Scarpiello, A., D'Erasmo, E., Minisola, S. (2005) Vitamin D status as the major factor determining the circulating levels of parathyroid hormone: a study in normal subjects. Osteoporosis International, 16, 805-812.
19. Politou, M., Terpos, E., Anagnostopoulos, A., Szydlo, R., Laffan, M., Layton, M., Apperley, J.F., Dimopoulos, M.A. & Rahemtulla, A. (2004) Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS). British Journal of Haematology, 126, 686-689.
20. Pongchaiyakul, C., Nguyen, N.D., Jones, G., Center, J.R., Eisman, J.A. & Nguyen, T.V. (2005) Asymptomatic vertebral deformity as a major risk factor for subsequent fractures and mortality: a long term prospective study. Journal of Bone and Mineral Research, 20, 1349-1355.
21. Romagnoli, E., Carnevale, V., Nofroni, I., D'Erasmo, E., Paglia, F., De Geronimo, S., Pepe, J., Raejntroph, N., Maranghi, M. & Minisola, S. (2004) Quality of life in ambulatory postmenopausal women: the impact of reduced bone mineral density and subclinical vertebral fractures. Osteoporosis International, 15, 975-980.
22. Rosenquist, C., Fledelius, C., Christgau, S., Pedersen, B.J., Bonde, M., Qvist, P. & Christiansen. C. (1998) Serum CrossLaps one step ELISA. First application of monoclonal antibodies for measurement of bone-related degradation products from C-terminal telopeptides of type I collagen. Clinical Chemistry, 44, 2281-2289.
23. Terpos, E., Szydlo, R., Apperley, J.F., Hatjiharissi, E., Politou, M., Meletis, J., Viniou, N., Yataganas, X., Goldman, J.M. & Rahemtulla, A. (2003) Soluble receptor activator of nuclear factor-kappa B ligand- osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index. Blood, 102, 1064-1069.
24. Vogt, T.M., Ross, P.D., Palermo, L., Musliner, T., Genant, H.K., Black, D. & Thompson, D.E. (2000) Vertebral fracture prevalence among women screened for the Fracture Intervention Trial and a simple clinical tool to screen for undiagnosed vertebral fractures. Fracture Intervention Trial Research Group. Mayo Clinic Proceedings, 75, 888-896.
25. Woitge, H.W., Horn, E., Keck, A.V., Auler, B., Seibel, M.J. & Pecherstorfer, M. (2001) Biochemical markers of bone formation in patients with plasma cell dyscrasias and benign osteoporosis. Clinical Chemistry, 47, 686-693.